Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR)

57 filings reported holding BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share as of Q3 2022.
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 23,231,970 shares .
Largest 10 shareholders include Kynam Capital Management, LP (6,703,863 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (4,296,280 shares), BlackRock Inc. (1,558,060 shares), MILLENNIUM MANAGEMENT LLC (1,490,614 shares), BARCLAYS PLC (1,345,377 shares), ORBIMED ADVISORS LLC (1,282,816 shares), MORGAN STANLEY (914,986 shares), Sumitomo Mitsui Trust Holdings, Inc. (741,830 shares), Nikko Asset Management Americas, Inc. (741,830 shares), and RENAISSANCE TECHNOLOGIES LLC (540,800 shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.